A Study Aimed at Assessing the Pharmacokinetic Properties of RGB-10 and Forsteo

NCT02223416 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Gedeon Richter Plc.